HSS Study Finds AI Tool Improves Patient Readiness for Joint Replacement Surgery Preparing for major orthopedic procedures like hip or knee replacement can be an overwhelming experience for patients. The…
Align Technology Highlights Commitment to Digital Orthodontics and Clinical Excellence at 2025 Global Faculty Meeting Align Technology, Inc. (NASDAQ: ALGN), a global leader in medical devices known for its Invisalign®…
Covalon Technologies Ltd. Announces Leadership Transition: Abe Schwartz Returns as Board Chair Following Amir Boloor’s Departure Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF), a pioneering developer and manufacturer of advanced…
iCare USA Unveils ALTIUS: A Next-Generation Cloud Platform Poised to Transform Eye Care Imaging Eye care is entering a new digital era, and iCare USA is positioning itself at the…
Contrast-Enhanced Ultrasound Delivers Perfect Accuracy in Detecting Residual and Recurrent Kidney Tumors, Outperforming MRI and CT At the 39th Annual International Bubble Conference in Chicago, a groundbreaking study was unveiled…
Cryotherapy Device Market Outlook 2025–2030: Innovation, Expanding Applications, and Regional Growth The global cryotherapy device market, valued at USD 2.93 billion in 2024, is on track to reach USD 4.28…
ClearFlow to Showcase PleuraFlow Active Clearance Technology at Vizient Innovative Technology Exchange ClearFlow, Inc., a medical device company focused on advancing cardiothoracic surgery recovery through better chest drainage solutions, has…
Smart Medical Devices Market Outlook 2025–2030: Growth, Trends, and Future Opportunities The smart medical devices industry is entering a period of rapid expansion, fueled by technological innovations, growing healthcare needs,…
Otsuka Medical Devices Secures First Japanese Approval for Paradise™ Ultrasound Renal Denervation System to Treat Resistant Hypertension Otsuka Medical Devices Co., Ltd. has achieved a significant regulatory milestone with the…
Turiya Anesthesia, a leading provider of high-quality anesthesia services in Southern California, is thrilled to announce the expansion of its partnership with Emanate Health to now include Foothill Presbyterian Hospital…
Spine BioPharma, Inc. announced today the Phase 3 MODEL trial (MOderate – Severe Degenerative Disc Disease Evaluation of the Lumbar Spine) evaluating SB-01, a TGF-β antagonist for intradiscal treatment of patients with Chronic Low…
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the signing of an asset purchase agreement between Sanofi and Visirna Therapeutics, a majority-owned subsidiary of Arrowhead created to develop and commercialize four…